Related Experiment Video
Updated: Jun 4, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
PDA@Pt nanoparticles: Dual antiviral and anti-inflammatory effects against influenza A virus through multi-target
Xuexian Deng1, Zhixuan Chen1, Sizu Yang1
1Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Abstract:
Influenza A virus (IAV) infection can lead to severe complications, including acute lung injury, driven by hypoxia, excessive reactive oxygen species (ROS), and cytokine release syndrome (CRS). To address the limitations of current therapies, such as insufficient antiviral efficacy and poor CRS control, we developed polydopamine-platinum core-shell nanoparticles (PDA@Pt) with dual antiviral and anti-inflammatory functions. The PDA core scavenges ROS to alleviate CRS and disrupts viral replication, while the Pt shell inhibits viral entry and catalyzes the decomposition of H2O2 into O2 to relieve hypoxia. PDA@Pt demonstrated excellent biocompatibility and potent antiviral activity by suppressing viral replication through dual mechanisms: inhibition of clathrin-mediated endocytosis via downregulation of clathrin heavy chain and dynamin, and multimodal therapeutic effects via ROS scavenging, O2 generation, and suppression of proinflammatory cytokines. Furthermore, PDA@Pt modulated key signaling pathways, including JAK/STAT and NF-κB, highlighting its broad-spectrum potential against viral infections and associated inflammatory complications.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Influenza
Antiviral Nucleoside Inhibitors